Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Increase (Decrease) in Other Operating Assets and Liabilities, Net

2.8 / 5 stars · 68/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net

WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of -$108.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-02-17

  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2024-03-31 was $34.60M, a 26.07% decline year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2023-12-31 was -$53.30M.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2023-09-30 was -$24.80M, a 177.02% decline year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2023-06-30 was $25.30M, a 47.62% decline year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was -$108.10M.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$22.60M.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$6.00M.
  • WEST PHARMACEUTICAL SERVICES, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$54.70M.
Period endIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed
2025-12-31-$108.10M
10-K · filed 2026-02-17
2024-12-31-$22.60M
10-K · filed 2026-02-17
2024-03-31$34.60M
10-Q · filed 2024-04-25
-$18.70M
derived: sum of 2 quarters · filed 2026-02-17
-$43.50M
derived: sum of 3 quarters · filed 2026-02-17
-$18.20M
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31-$53.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$78.10M
derived: sum of 2 quarters · filed 2026-02-17
-$52.80M
derived: sum of 3 quarters · filed 2026-02-17
-$6.00M
10-K · filed 2026-02-17
2023-09-30-$24.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
$500.00K
derived: sum of 2 quarters · filed 2023-10-26
$47.30M
10-Q · filed 2023-10-26
-$138.10M
derived: sum of 4 quarters · filed 2025-02-18
2023-06-30$25.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27
$72.10M
10-Q · filed 2023-07-27
-$113.30M
derived: sum of 3 quarters · filed 2025-02-18
-$81.10M
derived: sum of 4 quarters · filed 2025-02-18
2023-03-31$46.80M
10-Q · filed 2024-04-25
-$138.60M
derived: sum of 2 quarters · filed 2025-02-18
-$106.40M
derived: sum of 3 quarters · filed 2025-02-18
-$58.10M
derived: sum of 4 quarters · filed 2025-02-18
2022-12-31-$185.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
-$153.20M
derived: sum of 2 quarters · filed 2025-02-18
-$104.90M
derived: sum of 3 quarters · filed 2025-02-18
-$54.70M
10-K · filed 2025-02-18
-$58.20M
10-K · filed 2023-02-21
2022-09-30$32.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
$80.50M
derived: sum of 2 quarters · filed 2023-10-26
$130.70M
10-Q · filed 2023-10-26
$16.30M
10-Q · filed 2022-10-27
$110.80M
derived: sum of 4 quarters · filed 2024-02-20
2022-06-30$48.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27
$98.50M
10-Q · filed 2023-07-27
$97.70M
10-Q · filed 2022-07-28
$78.60M
derived: sum of 3 quarters · filed 2024-02-20
-$72.40M
derived: sum of 4 quarters · filed 2024-02-20
2022-03-31$50.20M
10-Q · filed 2023-04-27
$30.30M
derived: sum of 2 quarters · filed 2024-02-20
-$120.70M
derived: sum of 3 quarters · filed 2024-02-20
-$47.10M
derived: sum of 4 quarters · filed 2024-02-20
2021-12-31-$19.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20
-$170.90M
derived: sum of 2 quarters · filed 2024-02-20
-$97.30M
derived: sum of 3 quarters · filed 2024-02-20
-$2.40M
10-K · filed 2024-02-20
-$6.70M
10-K · filed 2022-02-22
2021-09-30-$151.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
-$77.40M
derived: sum of 2 quarters · filed 2022-10-27
$17.50M
10-Q · filed 2022-10-27
-$59.90M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30$73.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28
$168.50M
10-Q · filed 2022-07-28
$10.90M
10-Q · filed 2021-07-30
$91.10M
derived: sum of 3 quarters · filed 2023-02-21
$95.70M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31$94.90M
10-Q · filed 2022-04-28
$17.50M
derived: sum of 2 quarters · filed 2023-02-21
$22.10M
derived: sum of 3 quarters · filed 2023-02-21
-$18.60M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31-$77.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
-$72.80M
derived: sum of 2 quarters · filed 2023-02-21
-$113.50M
derived: sum of 3 quarters · filed 2023-02-21
-$67.90M
10-K · filed 2023-02-21
2020-09-30$4.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
-$36.10M
derived: sum of 2 quarters · filed 2021-10-28
$9.50M
10-Q · filed 2021-10-28
$25.40M
10-Q · filed 2020-10-23
-$16.40M
derived: sum of 4 quarters · filed 2022-02-22
2020-06-30-$40.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$4.90M
10-Q · filed 2021-07-30
-$21.00M
derived: sum of 3 quarters · filed 2022-02-22
-$6.00M
derived: sum of 4 quarters · filed 2022-02-22
2020-03-31$45.60M
10-Q · filed 2021-04-30
$4.30M
10-Q · filed 2020-04-24
$19.70M
derived: sum of 2 quarters · filed 2022-02-22
$34.70M
derived: sum of 3 quarters · filed 2022-02-22
$35.20M
derived: sum of 4 quarters · filed 2022-02-22
2019-12-31-$25.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
-$10.90M
derived: sum of 2 quarters · filed 2022-02-22
-$10.40M
derived: sum of 3 quarters · filed 2022-02-22
-$9.60M
10-K · filed 2022-02-22
2019-09-30$15.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23
$15.50M
derived: sum of 2 quarters · filed 2020-10-23
$16.30M
10-Q · filed 2020-10-23
$600.00K
10-Q · filed 2019-10-29
-$16.00M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30$500.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24
$1.30M
10-Q · filed 2020-07-24
-$31.00M
derived: sum of 3 quarters · filed 2021-02-23
-$30.40M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$800.00K
10-Q · filed 2020-04-24
-$31.50M
derived: sum of 2 quarters · filed 2021-02-23
-$30.90M
derived: sum of 3 quarters · filed 2021-02-23
-$30.20M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31-$32.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
-$31.70M
derived: sum of 2 quarters · filed 2021-02-23
-$31.00M
derived: sum of 3 quarters · filed 2021-02-23
-$28.30M
10-K · filed 2021-02-23
2018-09-30$600.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29
$1.30M
derived: sum of 2 quarters · filed 2019-10-29
$4.00M
10-Q · filed 2019-10-29
$11.80M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30$700.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29
$3.40M
10-Q · filed 2019-07-29
$11.20M
derived: sum of 3 quarters · filed 2020-02-24
$10.80M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31$2.70M
10-Q · filed 2019-05-08
$10.50M
derived: sum of 2 quarters · filed 2020-02-24
$10.10M
derived: sum of 3 quarters · filed 2020-02-24
$10.50M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$7.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$7.40M
derived: sum of 2 quarters · filed 2020-02-24
$7.80M
derived: sum of 3 quarters · filed 2020-02-24
$11.00M
10-K · filed 2020-02-24
2017-09-30-$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$0.00
derived: sum of 2 quarters · filed 2018-10-30
$3.20M
10-Q · filed 2018-10-30
$17.40M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31
$3.60M
10-Q · filed 2018-07-31
$17.80M
derived: sum of 3 quarters · filed 2019-02-28
$24.80M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$3.20M
10-Q · filed 2018-05-08
$17.40M
derived: sum of 2 quarters · filed 2019-02-28
$24.40M
derived: sum of 3 quarters · filed 2019-02-28
$20.10M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$14.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$21.20M
derived: sum of 2 quarters · filed 2019-02-28
$16.90M
derived: sum of 3 quarters · filed 2019-02-28
$17.90M
10-K · filed 2019-02-28
2016-09-30$7.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$2.70M
derived: sum of 2 quarters · filed 2017-10-31
$3.70M
10-Q · filed 2017-10-31
$51.10M
10-Q · filed 2016-10-31
-$51.50M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$4.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
-$3.30M
10-Q · filed 2017-08-01
$60.50M
10-Q · filed 2016-08-01
-$58.50M
derived: sum of 3 quarters · filed 2018-02-26
-$51.90M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$1.00M
10-Q · filed 2017-05-05
$60.00M
10-Q · filed 2016-05-06
-$54.20M
derived: sum of 2 quarters · filed 2018-02-26
-$47.60M
derived: sum of 3 quarters · filed 2018-02-26
-$60.20M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$55.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$48.60M
derived: sum of 2 quarters · filed 2018-02-26
-$61.20M
derived: sum of 3 quarters · filed 2018-02-26
-$100.00K
10-K · filed 2018-02-26
2015-09-30$6.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31
-$6.00M
derived: sum of 2 quarters · filed 2016-10-31
$55.10M
10-Q · filed 2016-10-31
$11.80M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$12.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01
$48.50M
10-Q · filed 2016-08-01
$5.20M
derived: sum of 3 quarters · filed 2017-02-28
-$2.20M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$61.10M
10-Q · filed 2016-05-06
$17.80M
derived: sum of 2 quarters · filed 2017-02-28
$10.40M
derived: sum of 3 quarters · filed 2017-02-28
$10.80M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$43.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$50.70M
derived: sum of 2 quarters · filed 2017-02-28
-$50.30M
derived: sum of 3 quarters · filed 2017-02-28
-$7.10M
10-K · filed 2017-02-28
2014-09-30-$7.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
-$7.00M
derived: sum of 2 quarters · filed 2015-11-02
$36.20M
10-Q · filed 2015-11-02
$9.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03
$43.60M
10-Q · filed 2015-08-03
$16.40M
derived: sum of 3 quarters · filed 2016-02-26
$15.70M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$43.20M
10-Q · filed 2015-05-06
$16.00M
derived: sum of 2 quarters · filed 2016-02-26
$15.30M
derived: sum of 3 quarters · filed 2016-02-26
-$9.90M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31-$27.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
-$27.90M
derived: sum of 2 quarters · filed 2016-02-26
-$53.10M
derived: sum of 3 quarters · filed 2016-02-26
-$15.30M
10-K · filed 2016-02-26
2013-09-30-$700.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03
-$25.90M
derived: sum of 2 quarters · filed 2014-11-03
$11.90M
10-Q · filed 2014-11-03
-$31.90M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30-$25.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$12.60M
10-Q · filed 2014-08-01
-$31.20M
derived: sum of 3 quarters · filed 2015-02-25
-$43.40M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$37.80M
10-Q · filed 2014-05-08
-$6.00M
derived: sum of 2 quarters · filed 2015-02-25
-$18.20M
derived: sum of 3 quarters · filed 2015-02-25
-$18.20M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31-$43.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
-$56.00M
derived: sum of 2 quarters · filed 2015-02-25
-$56.00M
derived: sum of 3 quarters · filed 2015-02-25
-$19.70M
10-K · filed 2015-02-25
2012-09-30-$12.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
-$12.20M
derived: sum of 2 quarters · filed 2013-11-04
$24.10M
10-Q · filed 2013-11-04
$4.60M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
$36.30M
10-Q · filed 2013-08-05
$16.80M
derived: sum of 3 quarters · filed 2014-02-27
$11.40M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$36.30M
10-Q · filed 2013-05-06
$36.10M
10-Q · filed 2012-05-04
$16.80M
derived: sum of 2 quarters · filed 2014-02-27
$11.40M
derived: sum of 3 quarters · filed 2014-02-27
$12.40M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31-$19.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
-$24.90M
derived: sum of 2 quarters · filed 2014-02-27
-$23.90M
derived: sum of 3 quarters · filed 2014-02-27
$7.80M
10-K · filed 2014-02-27
2011-09-30-$5.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
-$4.40M
derived: sum of 2 quarters · filed 2012-11-05
$27.30M
10-Q · filed 2012-11-05
$47.60M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
$32.70M
10-Q · filed 2012-08-06
$53.00M
derived: sum of 3 quarters · filed 2013-02-27
$64.60M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$31.70M
10-Q · filed 2012-05-04
-$31.70M
10-Q · filed 2011-05-05
$52.00M
derived: sum of 2 quarters · filed 2013-02-27
$63.60M
derived: sum of 3 quarters · filed 2013-02-27
$56.10M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$20.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$31.90M
derived: sum of 2 quarters · filed 2013-02-27
$24.40M
derived: sum of 3 quarters · filed 2013-02-27
-$3.00M
10-K · filed 2013-02-27
$3.00M
10-K · filed 2011-02-28
2010-09-30$11.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$4.10M
derived: sum of 2 quarters · filed 2010-11-05
-$23.30M
10-Q · filed 2010-11-05
$1.60M
derived: sum of 4 quarters · filed 2012-03-01
2010-06-30-$7.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05
-$34.90M
10-Q · filed 2010-08-05
-$10.00M
derived: sum of 3 quarters · filed 2012-03-01
-$8.70M
derived: sum of 4 quarters · filed 2012-03-01
2010-03-31-$27.40M
10-Q · filed 2011-05-05
-$2.50M
derived: sum of 2 quarters · filed 2012-03-01
-$1.20M
derived: sum of 3 quarters · filed 2012-03-01
2009-12-31$24.90M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01
$26.20M
derived: sum of 2 quarters · filed 2012-03-01
$2.40M
10-K/A · filed 2012-03-01
-$2.40M
10-K · filed 2011-02-28
2009-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
-$22.50M
10-Q · filed 2010-11-05
2009-06-30-$23.80M
10-Q · filed 2010-08-05
2008-12-31-$14.60M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44